Immunic Inc (IMUX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,730 | -4,933 | -14,388 | -52,078 | -37,490 |
| Depreciation Amortization | 10 | 7 | 224 | 998 | 780 |
| Accounts payable and accrued liabilities | 195 | 529 | -145 | 287 | 211 |
| Other Working Capital | 427 | 718 | -548 | 4,948 | 2,587 |
| Other Operating Activity | -195 | -529 | 1,783 | 5,448 | 3,435 |
| Operating Cash Flow | $-6,293 | $-4,208 | $-13,074 | $-40,397 | $-30,477 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -12 | -7 | -150 | -678 | -567 |
| Investing Cash Flow | $-12 | $-7 | $-150 | $-678 | $-567 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | 38,003 | 37,530 |
| Other Financing Activity | 12,564 | 12,564 | -30 | -19 | -86 |
| Financing Cash Flow | $12,564 | $12,564 | $-30 | $37,984 | $37,444 |
| Exchange Rate Effect | -743 | -722 | N/A | 1 | N/A |
| Beginning Cash Position | 4,504 | 4,504 | 56,901 | 59,991 | 59,991 |
| End Cash Position | 10,020 | 12,131 | 43,647 | 56,901 | 66,391 |
| Net Cash Flow | $5,516 | $7,627 | $-13,254 | $-3,090 | $6,400 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,293 | -4,208 | -13,074 | -40,397 | -30,477 |
| Capital Expenditure | -12 | -7 | -150 | -685 | -574 |
| Free Cash Flow | -6,305 | -4,215 | -13,224 | -41,082 | -31,051 |